Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
NeuroBo Pharmaceuticals, Inc. (GEMP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/12/2023 |
3
| Glickman Mark A (Director) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 01/18/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/22/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/02/2022 |
3
| STRICKLAND D GORDON (Director) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 11/04/2021 |
3
| Price Ben Gil (CEO and President) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 07/19/2021 |
3
| Kim Hyung Heon (Director) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 07/19/2021 |
3
| KOVEN ANDREW I (Director) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 01/05/2021 |
3
| Bakshi Akash (SVP and COO) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 09/03/2020 |
3
| Swirsky Douglas J (Director) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 01/09/2020 |
3
| JK BioPharma Solutions, Inc (10% Owner) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 01/09/2020 |
3
| E&Investment, Inc. (10% Owner) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 01/09/2020 |
3
| DONG-A ST CO., LTD (10% Owner) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 01/02/2020 |
3
| Oh Jeong Gyun (Director) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 01/02/2020 |
3
| Kim Na Yeon (Director) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 01/02/2020 |
3
| Kang Jeong Gu (Director) has filed a Form 3 on NeuroBo Pharmaceuticals, Inc. |
| 12/30/2019 |
3
| Shannon Nicola (VP, Clinical Operations) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 12/30/2019 |
3
| Versavel Mark (Chief Medical Officer) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 12/30/2019 |
3
| Salsbury Michael (Director) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 12/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 12/30/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/06/2016 |
3
| Golden Lee Scott (Chief Medical Officer) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| SASSINE ANDY (Director) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| LICHTINGER PEDRO (Director) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| KOUSKY KENNETH W (Director) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| Hawryluk P. Kent (Director) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| Gullans Steven R. Ph.D. (Director) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| Sooch Mina (President, CEO & Treasurer) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| Reno Seth (Chief Commercial Officer) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| Oniciu Carmen Daniela (VP of PreClinical R&D & Manf.) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| MATHIESEN JEFFREY S (CFO) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| Lowenschuss David (Chief Legal Off. & Secretary) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| Bisgaier Charles PhD (Chair & Chief Scientific Off.) has filed a Form 3 on Gemphire Therapeutics Inc. |
|
|